Literature DB >> 23431676

Progressive multifocal leukoencephalopathy: cavitary white matter lesions.

Caroline Raasch Alquist1, Robin McGoey, Luis Del Valle.   

Abstract

Progressive Multifocal Leukoencephalopathy (PML) is a fatal demyelinating disorder of the central nervous system caused by the opportunistic neurotropic Polyomavirus JCV. PML typically presents in immunocompromised individuals; is considered an AIDS defining condition; and is clinically characterized by cognitive defects, coordination problems, limb paresis, and speech disturbances. MRI can identify the characteristic bilaterally asymmetrical lesions that favor the subcortical frontal and parietal lobes as hypo-intensities on T1-weighted images and as hyper-intensities on T2-weighted images. Grossly, these areas appear discolored by a dusky, yellow-brown hue with the rare appearance of cavitation. No known therapeutic agent can specifically halt the progression of PML, and survival time after diagnosis averages less than two years. In this submission, we present a photo depicting striking lesions of severe PML of the cavitary type.

Entities:  

Mesh:

Year:  2012        PMID: 23431676      PMCID: PMC4153732     

Source DB:  PubMed          Journal:  J La State Med Soc        ISSN: 0024-6921


  14 in total

Review 1.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

2.  Drug-induced PML: a global agenda for a global challenge.

Authors:  M Vinhas de Souza; B Keller-Stanislawski; K Blake; A Hidalgo-Simon; P Arlett; G Dal Pan
Journal:  Clin Pharmacol Ther       Date:  2012-02-29       Impact factor: 6.875

Review 3.  Imaging manifestations of progressive multifocal leukoencephalopathy.

Authors:  R Shah; A K Bag; P R Chapman; J K Curé
Journal:  Clin Radiol       Date:  2010-06       Impact factor: 2.350

Review 4.  Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV).

Authors:  Wendy A Knowles
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

Review 5.  HIV disorders of the brain: pathology and pathogenesis.

Authors:  Luis Del Valle; Sergio Piña-Oviedo
Journal:  Front Biosci       Date:  2006-01-01

6.  Neuropathology and general autopsy findings in AIDS during the last 15 years.

Authors:  K A Jellinger; U Setinek; M Drlicek; G Böhm; A Steurer; F Lintner
Journal:  Acta Neuropathol       Date:  2000-08       Impact factor: 17.088

7.  Progressive multifocal leukoencephalopathy in patients with HIV infection.

Authors:  J R Berger; L Pall; D Lanska; M Whiteman
Journal:  J Neurovirol       Date:  1998-02       Impact factor: 2.643

8.  Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases.

Authors:  Eamonn S Molloy; Leonard H Calabrese
Journal:  Arthritis Rheum       Date:  2009-12

9.  Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.

Authors:  Frederik Neess Engsig; Ann-Brit Eg Hansen; Lars Haukali Omland; Gitte Kronborg; Jan Gerstoft; Alex Lund Laursen; Court Pedersen; Christian Backer Mogensen; Lars Nielsen; Niels Obel
Journal:  J Infect Dis       Date:  2009-01-01       Impact factor: 5.226

10.  Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.

Authors:  Jacques Gasnault; Dominique Costagliola; Houria Hendel-Chavez; Anne Dulioust; Sophie Pakianather; Anne-Aurélie Mazet; Marie-Ghislaine de Goer de Herve; Rémi Lancar; Anne-Sophie Lascaux; Lydie Porte; Jean-François Delfraissy; Yassine Taoufik
Journal:  PLoS One       Date:  2011-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.